RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
Chimge NO, Little GH, Baniwal SK, Adisetiyo H, Xie Y, Zhang T, O'Laughlin A, Liu ZY, Ulrich P, Martin A, Mhawech-Fauceglia P, Ellis MJ, Tripathy D, Groshen S, Liang C, Li Z, Schones DE, Frenkel B.
Chimge NO, et al.
Nat Commun. 2016 Feb 26;7:10751. doi: 10.1038/ncomms10751.
Nat Commun. 2016.
PMID: 26916619
Free PMC article.